Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Nature Medicine

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nm1167PMID 15619631
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structural availability influences the capacity of autoantigenic epitopes to induce a widespread lupus-like autoimmune response.

  2004cited by this paper
• Epstein-Barr Virus and Cancer

  2004cited by this paper
• Defective Control of Latent Epstein-Barr Virus Infection in Systemic Lupus Erythematosus1

  2004cited by this paper
• Infectious mononucleosis patients temporarily recognize a unique, cross‐reactive epitope of Epstein‐Barr virus nuclear antigen‐1

  2003cited by this paper
• Development of autoantibodies before the clinical onset of systemic lupus erythematosus.

  2003cited by this paper
• Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea

  2003cited by this paper
• Intrinsic T Cell Defects in Systemic Autoimmunity

  2003cited by this paper
• Autoimmunity due to molecular mimicry as a cause of neurological disease

  2002cited by this paper
• Anti-Sm Autoantibodies in Systemic Lupus Target Highly Basic Surface Structures of Complexed Spliceosomal Autoantigens1

  2002cited by this paper
• Selective Small Antigenic Structures are Capable of Inducing Widespread Autoimmunity which Closely Mimics the Humoral Fine Specificity of Human SLE

  2002cited by this paper
• Epstein–Barr Virus and Cancer

  2001cited by this paper
• Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.

  2001cited by this paper
• Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure.

  2001cited by this paper
• A virus-induced molecular mimicry model of multiple sclerosis.

  2001cited by this paper
• A virus-induced molecular mimicry model of multiple sclerosis.

  2001cited by this paper
• The role of Epstein-Barr virus in systemic lupus erythematosus.

  2001cited by this paper
• Can B cell epitopes of 60 kDa Ro distinguish systemic lupus erythematosus from Sjögren's syndrome?

  2001cited by this paper
• Ro60 Peptides Induce Antibodies to Similar Epitopes Shared Among Lupus-Related Autoantigens1

  2000cited by this paper
• Shared Early Autoantibody Recognition Events in the Development of Anti‐Sm B/B' in Human Lupus

  1999cited by this paper
• Immune Responses to Ro60 and Its Peptides in Mice. I.  The Nature of the Immunogen and Endogenous Autoantigen Determine the Specificities of the Induced Autoantibodies

  1999cited by this paper
• Structural, Molecular and Immunological Properties of Linear B‐Cell Epitopes of Ro60KD Autoantigen

  1998cited by this paper
• A novel epitope on the C-terminus of SmD1 is recognized by the majority of sera from patients with systemic lupus erythematosus.

  1998cited by this paper
• Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

  1997cited by this paper
• Lupus Humoral Autoimmunity after Short Peptide Immunization a

  1997cited by this paper
• Human Anti-Ro Autoantibodies Bind Multiple Conformational Epitopes of 60-kD Ro Autoantigen

  1997cited by this paper
• An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus.

  1997cited by this paper
• Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires.

  1996cited by this paper
• Epstein-Barr virus-induced autoimmune responses. II. Immunoglobulin G autoantibodies to mimicking and nonmimicking epitopes. Presence in autoimmune disease.

  1995cited by this paper
• Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein‐Barr virus‐encoded nuclear antigen EBNA I

  1993cited by this paper
• Linear epitope mapping of an Sm B/B' polypeptide.

  1992cited by this paper
• Epitopes of streptococcal M proteins shared with cardiac myosin

  1985cited by this paper

• Plasmablast Storms: Microbial Drivers of Acute and Chronic Autoimmune Flares

  2026cites this paper
• Epstein–Barr virus infection and rheumatic diseases

  2026cites this paper
• Vientovirus capsid protein mimics autoantigens and contributes to autoimmunity in Sjögren’s disease

  2025cites this paper
• Epstein-Barr virus reprograms autoreactive B cells as antigen-presenting cells in systemic lupus erythematosus.

  2025cites this paper
• Antibody repertoire associated with clinically diverse presentations of pediatric SARS-CoV-2 infection

  2025cites this paper
• EBV and Autoimmunity.

  2025cites this paper
• Molecular Mimicry Between Toxoplasma gondii B-Cell Epitopes and Human Antigens Related to Schizophrenia: An In Silico Approach

  2025cites this paper
• Immunpathogenese und Therapie der Primär Sklerosierenden Cholangitis

  2025cites this paper
• Molecular mimicry in the pathogenesis of autoimmune rheumatic diseases

  2025influential citation
• T and B cell responses against Epstein–Barr virus in primary sclerosing cholangitis

  2025cites this paper
• Web of Science‐Based Visualization of Mapping Global Scientific Production on Epstein–Barr Virus‐Associated Autoimmune Diseases: A Bibliometric Study

  2025cites this paper
• Epstein‐Barr Virus (EBV) and Autoimmune Diseases: Pathogenic Mechanisms and Therapeutic Insights

  2025cites this paper
• Immune responses to infection and autoimmune diseases in the UK biobank

  2025cites this paper
• Epstein-Barr Virus (EBV)-Specific Humoral Immune Responses in Health and Disease.

  2025cites this paper
• Systematic investigation of Epstein-Barr virus transcriptional regulator interactions with the human genome

  2025cites this paper
• Herpesvirus initiation of dementias and autoimmune diseases

  2025cites this paper
• The Role of Epstein–Barr Virus Molecular Mimicry in Various Autoimmune Diseases

  2025cites this paper
• Exploring the Association between Epstein-Barr Virus and Systemic Lupus Erythematosus: Insights into Viral Triggers

  2025cites this paper
• Chronic inflammation in Long COVID relationship to autoimmune diseases.

  2025cites this paper
• Is Epstein Barr virus latency protective against type 1 diabetes?

  2024cites this paper
• Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome

  2024cites this paper
• Epstein-Barr virus reactivation and disease flare of systemic lupus erythematosus.

  2024cites this paper
• Viral mimicry and endocrine system: Divulging the importance in host-microbial crosstalk.

  2024cites this paper
• Protective and Stochastic Correlation Between Infectious Diseases and Autoimmune Disorders.

  2024cites this paper
• Infectious agents in the pathogenesis of autoimmune rheumatic diseases.

  2024cites this paper
• Ro60—Roles in RNA Processing, Inflammation, and Rheumatic Autoimmune Diseases

  2024cites this paper
• Evidence that autoantibody production may be driven by acute Epstein-Barr virus infection in Sjögren’s disease

  2024cites this paper
• An IL-17A-centric response to Epstein-Barr virus DNA mediated by dendritic Cell-T cell interactions

  2024cites this paper
• Epstein–Barr virus as a potentiator of autoimmune diseases

  2024cites this paper
• Association of gut commensal translocation with autoantibody production in systemic lupus erythematosus.

  2024cites this paper
• Characterization of anti-EBNA-1 antibodies and exploration of their molecular mimicry potential in an EBV-infected Sjögren's syndrome patient.

  2024cites this paper
• The role of Epstein-Barr virus in autoimmune and autoinflammatory diseases

  2024cites this paper
• Epstein–Barr Viruses: Their Immune Evasion Strategies and Implications for Autoimmune Diseases

  2024cites this paper
• The impact of the human gut microbiome on the treatment of autoimmune disease

  2024cites this paper
• The role of gut microbiota in different murine models of systemic lupus erythematosus

  2024cites this paper
• BCR signaling is required for posttransplant lymphoproliferative disease in immunodeficient mice receiving human B cells

  2024cites this paper
• The immunology of systemic lupus erythematosus

  2024cites this paper
• The role of Epstein-Barr virus in systemic lupus erythematosus

  2023cites this paper
• Epstein-Barr virus reactivation in peripheral B lymphocytes induces IgM-type thyrotropin receptor autoantibody production in patients with Graves' disease.

  2023cites this paper
• TLR7 activation of age-associated B cells mediates disease in a mouse model of primary Sjögren's disease.

  2023cites this paper
• Alterations of the gut microbiota in the lupus nephritis: a systematic review

  2023cites this paper
• The Role of Viral Infections in the Onset of Autoimmune Diseases

  2023cites this paper
• Intestinal homeostasis in the gut-lung-kidney axis: a prospective therapeutic target in immune-related chronic kidney diseases

  2023influential citation
• High-throughput autoantibody screening identifies differentially abundant autoantibodies in autism spectrum disorder

  2023cites this paper
• Targeting alarmin release reverses Sjogren's syndrome phenotype by revitalizing Ca2+ signalling

  2023cites this paper
• Antibody Cross-Reactivity in Auto-Immune Diseases

  2023cites this paper
• Exploring the Complex Relationship Between Microbiota and Systemic Lupus Erythematosus

  2023cites this paper
• The heterophilicic epitopes in conserved HA regions of human and avian influenza viruses can produce antibodies that bound to kidney tissue.

  2023cites this paper
• Chronic Epstein-Barr virus infection: A potential junction between primary Sjögren's syndrome and lymphoma.

  2023cites this paper
• Autoantibodies to Interferons in Infectious Diseases

  2023cites this paper
• Anti‐EBV antibodies: Roles in diagnosis, pathogenesis, and antiviral therapy

  2023cites this paper
• Serositis and lymphopenia are common features of systemic lupus erythematosus following SARS‐CoV‐2 infection: A case report and literature review

  2023cites this paper
• Fecal microbiota transplantation in the treatment of systemic lupus erythematosus: What we learnt from the explorative clinical trial.

  2023cites this paper
• The axis of complement C1 and nucleolus in antinuclear autoimmunity

  2023cites this paper
• Markers of Epstein-Barr Virus Infection in Patients with Multiple Sclerosis

  2023cites this paper
• Identification of Heterophilic Epitopes of H1N1 Influenza Virus Hemagglutinin

  2023cites this paper
• Epstein–Barr virus and multiple sclerosis: moving from questions of association to questions of mechanism

  2023cites this paper
• Microbial dysbiosis in the gut drives systemic autoimmune diseases

  2022cites this paper
• Gut Barrier Damage and Gut Translocation of Pathogen Molecules in Lupus, an Impact of Innate Immunity (Macrophages and Neutrophils) in Autoimmune Disease

  2022cites this paper
• Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies.

  2022cites this paper
• Virus Infections Play Crucial Roles in the Pathogenesis of Sjögren’s Syndrome

  2022influential citation
• The association between hydroxychloroquine use and future development of systemic lupus erythematosus in patients with primary Sjögren's syndrome

  2022cites this paper
• [Epstein-Barr Virus and systemic lupus: Which connections?]

  2022cites this paper
• ImitateDB: A database for domain and motif mimicry incorporating host and pathogen protein interactions

  2022cites this paper
• Association of Viral Infection With the Development and Pathogenesis of Systemic Lupus Erythematosus

  2022cites this paper
• The Role of Clinical Features and Serum Biomarkers in Identifying Patients with Incomplete Lupus Erythematosus at Higher Risk of Transitioning to Systemic Lupus Erythematosus: Current Perspectives

  2022cites this paper
• The Prevalence and Clinical Relevance of the DFS Immunofluorescence Staining Pattern in a Large ANA-Positive Cohort

  2022cites this paper
• A High Prevalence of Anti-EBNA1 Heteroantibodies in Systemic Lupus Erythematosus (SLE) Supports Anti-EBNA1 as an Origin for SLE Autoantibodies

  2022cites this paper
• Applying Early Intervention Strategies to Autoimmune Skin Diseases. Is the Window of Opportunity Preclinical? A Dermato-Rheumatology Perspective.

  2022cites this paper
• From risk to chronicity: evolution of autoreactive B cell and antibody responses in rheumatoid arthritis

  2022cites this paper
• Epstein-Barr virus and multiple sclerosis

  2022cites this paper
• Association of Human Leucocyte Antigen Class II, with viral load and immune response to Epstein–Barr virus in adult and pediatric Systemic lupus erythematosus patients

  2022cites this paper
• When a virus lies in wait

  2021cites this paper
• Gut Microbiome and Metabolites in Systemic Lupus Erythematosus: Link, Mechanisms and Intervention

  2021cites this paper
• The role of CD8+ T-cell systemic lupus erythematosus pathogenesis: an update

  2021cites this paper
• Myelodysplastic Syndrome as a Cause of Refractory Bicytopaenia in Systemic Lupus Erythematosus

  2021cites this paper
• Infections in early systemic lupus erythematosus pathogenesis

  2021cites this paper
• Global discovery of lupus genetic risk variant allelic enhancer activity

  2021cites this paper
• The Autoantigen Repertoire and the Microbial RNP World.

  2021cites this paper
• Viral Infections and Systemic Lupus Erythematosus: New Players in an Old Story

  2021cites this paper
• Epstein Barr Virus and Autoimmune Responses in Systemic Lupus Erythematosus

  2021cites this paper
• Epstein-Barr Functional Mimicry: Pathogenicity of Oncogenic Latent Membrane Protein-1 in Systemic Lupus Erythematosus and Autoimmunity

  2021influential citation
• Antibodies to an Epstein Barr Virus protein that cross-react with dsDNA have pathogenic potential.

  2021cites this paper
• Autoantibodies against complement component C1q in systemic lupus erythematosus

  2021cites this paper
• An Overview of Neonatal Lupus with Anti-Ro Characteristics

  2021cites this paper
• The role of infections in SLE pathogenesis

  2021cites this paper
• Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosus

  2021cites this paper
• Recent advances in understanding the genetic basis of systemic lupus erythematosus

  2021cites this paper
• Epstein-Barr Virus and Systemic Autoimmune Diseases

  2021cites this paper
• Epithelial–immune cell interplay in primary Sjögren syndrome salivary gland pathogenesis

  2021cites this paper
• Revisiting B cell tolerance and autoantibodies in seropositive and seronegative autoimmune rheumatic disease (AIRD)

  2020cites this paper
• Clinical Validity of Serum Antibodies to SARS-CoV-2

  2020cites this paper
• Women's Health in Autoimmune Diseases

  2020cites this paper
• Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma

  2020cites this paper
• Epstein–Barr Virus Reactivation-Induced Immunoglobulin Production: Significance on Autoimmunity

  2020cites this paper
• Interferon activation status underlies higher antibody response to viral antigens in patients with systemic lupus erythematosus receiving no or light treatment.

  2020cites this paper
• Environmental factors in the pathogenesis of primary Sjögren's syndrome

  2020cites this paper
• A possible role for autoimmunity through molecular mimicry in alphavirus mediated arthritis

  2020cites this paper
• Genome-wide discovery of SLE genetic risk variant allelic enhancer activity

  2020cites this paper
• Microbial Infection as a Trigger of T-Cell Autoimmunity

  2020cites this paper